TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.77E+3nMpH: 7.4Assay Description:1321N1 cells expressing the recombinant human, rat or mouse P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high gluc...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.77E+3nMAssay Description:Human or rat P2X7-1321N1 cells were collected and frozen @ −80° C. On the day of the experiment, cell membrane preparations were made according...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.77E+3nMAssay Description:Human or rat P2X7-1321N1 cells were collected and frozen @ −80° C. On the day of the experiment, cell membrane preparations were made according...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.77E+3nMAssay Description:1321N1 cells expressing the recombinant human or rat P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high glucose...More data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMpH: 7.4Assay Description:1321N1 cells expressing the recombinant human, rat or mouse P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high gluc...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:1321N1 cells expressing the recombinant human or rat P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high glucose...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:1321N1 cells expressing the recombinant human or rat P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high glucose...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:1321N1 cells expressing the recombinant human or rat P2X7 channel was cultured in HyQ DME/(HyClone/Dulbecco's Modified Eagle Medium) high glucose...More data for this Ligand-Target Pair